XML 51 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring Actions (Tables)
12 Months Ended
Dec. 31, 2020
2020 Restructuring Actions | Operational/Marketing Capability Restructuring  
Restructuring Cost and Reserve  
Schedule of restructuring charges by income statement line

(Millions)

    

Fourth Quarter 2020

Cost of sales

$

51

Selling, general and administrative expenses

 

79

Research, development and related expenses

 

7

Total operating income impact

$

137

Components of restructuring by business segment

Fourth Quarter 2020

(Millions)

    

Employee-Related

    

Asset-Related and Other

    

Total

Safety and Industrial

$

36

$

7

$

43

Transportation and Electronics

16

12

28

Health Care

23

3

26

Consumer

10

1

11

Corporate and Unallocated

 

16

 

13

 

29

Total Operating Expense

$

101

$

36

$

137

Accrued restructuring action balances

(Millions)

    

Employee-Related

    

Asset-Related and Other

    

Total

Expense incurred in the fourth quarter of 2020

$

101

$

36

$

137

Non-cash changes

(36)

(36)

Accrued restructuring action balances as of December 31, 2020

$

101

$

$

101

2020 Restructuring Actions | Drug delivery business  
Restructuring Cost and Reserve  
Schedule of restructuring charges by income statement line

(Millions)

    

Second Quarter 2020

 

Cost of sales

$

42

Selling, general and administrative expenses

 

12

Research, development and related expenses

 

1

Total operating income impact

$

55

Accrued restructuring action balances

(Millions)

    

Employee-Related

    

Asset-Related and Other

    

Total

 

Expense incurred in the second quarter of 2020

$

32

$

23

$

55

Non-cash changes

(14)

(14)

Cash payments

 

(14)

 

 

(14)

Adjustments

(3)

(3)

Accrued divestiture-related restructuring action balances as of December 31, 2020

$

15

$

9

$

24

2020 Restructuring Actions | Other Restructuring  
Restructuring Cost and Reserve  
Schedule of restructuring charges by income statement line

(Millions)

    

Second Quarter 2020

 

Cost of sales

$

13

Selling, general and administrative expenses

 

37

Research, development and related expenses

 

8

Total operating income impact

$

58

Components of restructuring by business segment

Second Quarter 2020

(Millions)

    

Employee-Related

    

Asset-Related and Other

    

Total

 

Safety and Industrial

$

7

$

$

7

Transportation and Electronics

11

11

Health Care

12

12

Consumer

5

5

Corporate and Unallocated

 

 

23

 

23

Total Operating Expense

$

35

$

23

$

58

Accrued restructuring action balances

(Millions)

    

Employee-Related

    

Asset-Related

    

Total

 

Expense incurred in the second quarter of 2020

$

35

$

23

$

58

Non-cash changes

(23)

(23)

Cash payments

 

(2)

 

 

(2)

Adjustments

(9)

(9)

Accrued restructuring action balances as of December 31, 2020

$

24

$

$

24

2019 Restructuring Actions  
Restructuring Cost and Reserve  
Schedule of restructuring charges by income statement line

(Millions)

    

Second and Fourth Quarter 2019

 

Cost of sales

$

72

Selling, general and administrative expenses

 

137

Research, development and related expenses

 

37

Total operating income impact

246

Other expense (income), net

36

Total income before income taxes impact

$

282

Components of restructuring by business segment

Second and Fourth Quarter 2019

(Millions)

    

Employee-Related

    

Asset-Related

    

Total

 

Safety and Industrial

$

50

$

$

50

Transportation and Electronics

31

31

Health Care

17

17

Consumer

8

8

Corporate and Unallocated

 

100

 

40

 

140

Total Operating Expense

$

206

$

40

$

246

Accrued restructuring action balances

(Millions)

    

Employee-Related

    

Asset-Related

    

Total

 

Expense incurred in the second quarter and fourth quarter of 2019

$

242

$

40

$

282

Non-cash changes

(36)

(40)

(76)

Cash payments

 

(52)

 

 

(52)

Adjustments

(14)

(14)

Accrued restructuring action balances as of December 31, 2019

$

140

$

$

140

Cash Payments

(51)

(51)

Adjustments

(59)

(59)

Accrued restructuring action balances as of December 31, 2020

$

30

$

$

30

2018 Restructuring Actions  
Restructuring Cost and Reserve  
Schedule of restructuring charges by income statement line

(Millions)

Second and Fourth Quarter 2018

Cost of sales

$

27

Selling, general and administrative expenses

 

105

Research, development and related expenses

 

5

Total

$

137

Accrued restructuring action balances

(Millions)

    

Employee-Related

    

Asset-Related

    

Total

 

Expense incurred in the second quarter and fourth quarter of 2018

$

125

$

12

$

137

Non-cash changes

(12)

(12)

Cash payments

(24)

(24)

Adjustments

 

(17)

 

 

(17)

Accrued restructuring action balances as of December 31, 2018

$

84

$

$

84

Cash payments

 

(76)

 

 

(76)

Adjustments

(5)

(5)

Accrued restructuring action balances as of December 31, 2019

$

3

$

$

3